Pathway to Cures Announces Venture Investment in Five Liters
NEW YORK--(BUSINESS WIRE)--Oct 16, 2023--Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders. Pathway to Cures, an affiliate of the National Bleeding ...

